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B
lood pressure (BP) is a complex quantitative trait that is the consequence of an interaction between genetic and environmental determinants. 1, 2 Genetic factors account for only 30% of intraindividual BP variability, with the most common forms of hypertension resulting from the cumulative burden of genetic variation at multiple loci with environmental determinants. Further confounding genetic discovery for this trait is the high variability of intraindividual BP measures. 3 Thus, the detection of genes and variants contributing to variation in BP and hypertension has proven to be a significant challenge.
Two strategies that have been used effectively to detect genetic associations with modest size effects are to increase sample size, the approach of large-scale genome-wide association study (GWAS), and to perform long-term trait averaging to reduce variation. A combination of these approaches has led to the identification of a new genetic locus for hypertension, the KCNK3 gene, a 2-pore domain leak potassium channel 3 of long-term average BP in >40 000 individuals of European ancestry identified association between KCNK3 SNP rs1275988 with systolic BP (SBP) and mean arterial pressure (MAP), with replication in individuals of Chinese ancestry. 3 Subsequently, a larger cross-sectional GWAS of ≈100 000 individuals of European, East Asian, and South Asian ancestry confirmed association of this KCNK3 SNP with MAP. 4 Our study was motivated by the hypotheses that KCNK3 SNPs are associated with plasma aldosterone and renin, and the association of KCNK3 SNPs with BP traits extends to black and Hispanic race/ethnic groups. The first hypothesis is supported by several lines of evidence: (1) the unusually high expression of KCNK3 mRNA product, TASK-1, in the rodent and the human adrenal cortex 5 ; (2) the generation of aldosterone-related hypertension in mice produced by the tandem global deletion of genes (Kcnk3 and Kcnk9) encoding leak/background TASK K + channels 6 ; and (3) the consensus that aldosterone acts as a causative and pathogenic factor in hypertension.
To address the role of KCNK3 in the regulation of hypertension and aldosterone production in a multiethnic population, we performed a GWAS of KCNK3 SNPs with diastolic BP (DBP), SBP, MAP, pulse pressure, and prevalent hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA); we tested the same KCNK3 SNPs for associations with measures of aldosterone and renin in a subgroup of MESA and further examine replication of statistically significant SNPs in independent samples of the Atherosclerosis Risk in Communities (ARIC) study and the Framingham Heart Study (FHS; Figure  S1 in the online-only Data Supplement). We further examined aldosterone overproduction in mice in which only the Kcnk3 gene was deleted. Our studies extend the role of TASK-1 channels and variations in the coding gene (KCNK3) in hypertension and aldosterone production.
Methods

Study Design
The MESA is a longitudinal study of subclinical cardiovascular disease and risk factors that predict progression to clinically overt cardiovascular disease or subclinical disease. The first clinic visits occurred in 2000 to 2002 in which 6814 participants were recruited from 6 field centers across the United States; all participants were free of cardiovascular disease at the baseline examination. MESA and related ancillary studies were conducted under institutional review board approval of all participating studies sites including the University of Virginia with informed consent of all participants. The study was performed in accordance with the principles of the Declaration of Helsinki (additional details are available in the online-only Data Supplement).
Phenotyping of MESA Participants
At the baseline (examination 1) and main examinations for MESA Family Study and Air, BP was measured 3×; the average of the second and third readings was used for analysis. For the current analyses, measured BP was corrected for antihypertensive medication use by adding 10 mm Hg (SBP) and 5 mm Hg (DBP) to the observed values. 8, 9 Using these medication-adjusted BP values, we determined MAP (two-thirds DBP+one-third SBP), and pulse pressure (SBP−DBP). Hypertension status was defined as the presence of at least one of the following (1) measured SBP >140 mm Hg, (2) measured DBP >90 mm Hg, or (3) antihypertensive medication use.
At MESA examinations 2 and 3 (≈3 and 4.5 years after examination 1, respectively), a random subsample of 1960 MESA participants had aldosterone levels and plasma renin activity (PRA) measured as a part of an ancillary study investigating renal artery disease. 10 
Genotype Data
Participants recruited into the MESA cohort (6814), MESA Family Study (2128 from 528 families), and MESA Air (5479 from MESA, 257 external cohort, and 490 from MESA Family Study) were genotyped in 2009 using the Affymetrix Human SNP Array 6.0. Combining these genome-wide genotypes with imputation to the 1000 Genomes Project, 11 there were 85, 192, 113, and 66 KCNK3 region SNPs available for genetic association analysis in MESA white, black, Hispanic, and Chinese, respectively (additional details are available in the online-only Data Supplement).
Measurement of Aldosterone in TASK-1 Knockout Mice
TASK-1 knockout mice were generated and backcrossed to a C57Bl/6J background as described previously. 6, 12 Male wild-type and T1 knockout mice habituated in metabolic cages were given free access to normal (NS, 0.3% Na + ), low (LS, 0.02% Na + ), and high (HS, 2.0% Na + ) Na + diets for 1 week. Twenty-four-hour urine samples were collected on the last 4 days of each diet and analyzed for aldosterone (radioimmunoassay; Siemens) and creatinine (colorimetric assay; Cayman Chemicals) concentrations. At the end of each dietary condition, tail vein samples were collected and plasma renin concentration was measured (radioimmunoassay; Diasorin). All animal studies were approved by the University of Virginia Institutional Review Board and conducted according to the standards of the National Institutes of Health Guide for Care and Use of Laboratory Animals. 6, 12, 13 
Statistical Analysis
Genetic Association Analysis in MESA
We performed genetic association analysis of DBP, SBP, MAP, pulse pressure, hypertension, aldosterone levels, and PRA. Primary analyses examined association combined across race/ethnic groups in MESA, with secondary analyses stratified by MESA race/ethnic groups. Analysis of aldosterone levels and PRA was conducted with adjustment for age, sex, study site, principal components of ancestry, whereas analysis of the BP traits included additional adjustment for age-squared and body mass index. Our approach to the genetic analyses is schematized in Figure S1 and detailed in the online-only Data Supplement.
Replication Analysis in ARIC and FHS
For those SNPs demonstrating association with BP traits and hypertension in MESA, we conducted replication analysis in the ARIC Study and the FHS. Following the selection criteria for MESA, we examined only those FHS participants aged ≥45 years and restricted both ARIC and FHS to those free of coronary heart disease events at the time of examination. Aldosterone measures in the FHS Offspring 14 and Generation 3 participants 15 were examined for replication of 1 aldosterone-associated SNP identified in MESA. Statistical analyses were conducted using regression models mirroring those used in MESA (additional details are provided in the online-only Data Supplement).
Analysis of Aldosterone in TASK-1 Knockout Mice
Aldosterone/creatinine ratio and PRC were log transformed because of unequal variance among dietary conditions and tested for significance (P<0.05) using 2-way ANOVA and Bonferroni post hoc analysis.
Results
Characteristics of the Study Sample
At baseline (2000) (2001) (2002) , MESA participants were a relatively healthy group across all race/ethnicities ( Table 1) . The median age at baseline (examination 1) was 60 to 63 years, with prevalence of diabetes mellitus ranging from 6.1% to 18.7%, and percentage who currently smoke ranging from 5.5% to 19.4%. Blacks had higher SBP (median, 133.5 mm Hg), DBP (median, 76.5 mm Hg), and MAP (median, 95.5 mm Hg) than the other race/ethnic groups (SBP: race-/ ethnic-specific median, 124.0-126.0 mm Hg; DBP: race-/ ethnic-specific median, 71.5-72.5 mm Hg; and MAP: race-/ ethnic-specific median, 89.5-90.8 mm Hg) and a greater percentage were on antihypertensive medication (blacks: 51.4%; other race/ethnicities: 28.1-35.2%). Aldosterone and PRA levels were lower in blacks (aldosterone: median, 11.8 ng/dL; PRA: median, 0.38 ng/mL per hour) than in other race/ethnic groups (aldosterone: race-/ethnic-specific median, 12.9-13.9 ng/dL; PRA: race-/ethnic-specific median, 0.53-0.67 ng/mL per hour), as reported previously in MESA. 10 More than 80% of participants classified as using antihypertensive medication at baseline reported using no >2 classes of medication (Table S1) . Among these participants, we observed expected differences in PRA with respect to medication exposure. Compared with nonhypertensives, renin levels were not statistically different in patients on α and calcium channel blockers (Table 2 ; P=0.34), were decreased in those on β-blockers (P=0.0001), and elevated markedly among patients on angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and diuretics (P<0.0001).
KCNK3 SNPs Across Race/Ethnic Groups in MESA and Association With BP Traits
KCNK3 rs1275988, previously reported in GWAS of MAP, 3, 4 is located 1.3kb 5′ of KCNK3 suggesting a potential role in gene regulation. Although there is no evidence for this SNP as a cis-eQTL, examining the full range of tissues from GTEx (http://www.gtexportal.org/home/) or using the Blood eQTL browser 16 (http://genenetwork.nl/bloodeqtlbrowser/). We examined race-/ethnic-specific evidence of association between rs1275988 and MAP in MESA and found significant association of the C allele in stratified analyses of MESA white (Table S2 ; P=0.025) and black (P=0.024) participants, with consistent direction of effect in MESA Chinese (not statistically significant). The rs1275988 genotype distribution in MESA Hispanic Americans deviated significantly from that expected under Hardy-Weinberg equilibrium assumptions and rs1275988 was not included in the analysis. Our finding of an association between rs1275988 and MAP in MESA blacks represents a novel replication of the rs1275988 SNP association, as blacks were not included in previous largescale GWAS efforts. 3, 4 In analysis of additional BP traits and prevalent hypertension, we identified associations in the full MESA cohort for KCNK3 rs1731243 with SBP ( (Table 3) as a covariate did not reveal any additional independently associated SNPs for these traits overall, or in race-/ethnic-specific analyses.
To further characterize the main associations identified with BP traits, we performed sensitivity analyses using different statistical models, relevant covariates, and stratification based on factors of additional interest. Notably, analyzing measured BP with covariate adjustment for antihypertensive medication exposure (Table S3) , we observed results qualitatively similar to our main analysis in which phenotypic outcomes Likelihood ratio test performed for comparison of participants on β-blockers, α-blockers, or calcium channel blockers without diuretics compared with those on thiazide diuretics with or without K-sparing agents, angiotensin receptor blockers (with or without diuretics), or angiotensin-converting enzyme inhibitors (with or without diuretics) for aldosterone levels (P=0.46) or plasma renin activity (P=3.0E−8) after covariate adjustment for sex, age and race/ethnicity. ACE indicates angiotensin-converting enzyme.
*Medication exposure groups are constructed by grouping together those participants with exposure to any of the indicated classes of medications, and excluding all other classes of medications indicated in Table S1 .
by guest on December 14, 2017 http://hyper.ahajournals.org/ Downloaded from were corrected for antihypertensive medication exposure. Similarly, results for our main SNP associations remained qualitatively similar after additional covariate adjustment for urinary sodium/creatinine ratio (Table S4) , and when longterm average BP traits (Table S5) were examined. In stratified analyses, we observed stronger evidence of association in participants aged >60 years versus those ≤60 years (Table  S6 ), in women versus men (Table S7) , and in postmenopausal versus premenopausal women (Table S8 ) although overall the observed directions of effect were consistent across subgroups.
KCNK3 SNPs and Variation in Aldosterone Levels and PRA in MESA
One KCNK3 SNP, rs2586886, demonstrated association with aldosterone levels in the MESA cohort (Table 4 ; P=3.0×10 -4 ). The rs2586886 SNP is in an intron of KCNK3, affecting both promoter and enhancer histone marks (HaploReg v4.1), and is in high LD with rs1275988 in Europeans and Asians from the 1000 Genomes ( Figure S2 , 1000G EUR and ASN r 2 >0.9), with reduced LD in Native Americans (1000G AMR r 2 =0.72) and no LD in Africans (1000G AFR r 2 =0.12). The association showed consistent directional effects across the 4 race/ethnic groups, with stronger effects observed in blacks and Chinese. In sensitivity analysis, we identified statistically significant evidence of heterogeneity for the association of rs2586886 with aldosterone based on antihypertensive medication exposure, with strong effects of the C allele on increased aldosterone levels observed only among individuals currently using antihypertensive medication (Table 4 ; Cochran Q heterogeneity P=0.004). To understand the significance of this finding, we examined the association of rs2586886 with aldosterone levels stratified by antihypertensive medication class (Table 2) . Patients were subdivided into 3 major groups based on the established class effect of their medication on the renin-angiotensin system. Patients on medications that suppress the system were included in group I (β-blockers only), those on drugs having little direct impact on the system, group II (α-blockers or calcium channel blockers), and those on medications that frankly stimulate renin group III (thiazide diuretics, angiotensin receptor blockers, or angiotensin-converting enzyme inhibitors, alone or in combination). In a combined analysis across race/ethnic groups, we observed consistent directional effects in all medication subgroups. Nevertheless, the strongest (and significant) evidence of association of rs2586886 with elevated aldosterone was observed for those patients in group III (A&B) on agents that stimulate renin (Table  S9) . Notably, exclusion of participants taking diuretics from group IIIA did not reduce the statistical significance of the association of aldosterone levels with rs2586886 (Table S9) , even though diuretic-induced augmentation of aldosterone levels was absent from subgroup IIIB ( Table 2) . Analysis of rs2586886 with aldosterone levels in those without hypertension was not statistically significant (Table S9 ; P=0.283), but the direction of effect was consistent with that seen in those on medication. Sex-stratified analysis of rs2586886 for aldosterone levels demonstrated comparable effect sizes in men and women (Table S10 , both nominal P<0.05). In addition, the C allele for the rs2586886 SNP also was associated with increases in measures of BP in the full MESA cohort (SBP, DBP, MAP, pulse pressure, and hypertension; Table S11; all nominal P<0.05), with consistent directions of effect in each of the 4 race/ethnic groups in MESA. There were no KCNK3 Genetic association results for medication-corrected blood pressure traits reported under an additive 1 df SNP dosage model. Analysis of blood pressure traits and prevalent hypertension conducted with adjustment for sex, age, age2, body mass index, study site and race-/ethnic-specific principal components of ancestry. HTN indicates hypertension; MAP, mean arterial pressure; SBP, systolic blood pressure; and SNP, single nucleotide polymorphism.
*Most strongly associated SNP in meta-analysis for the indicated gene and trait.
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SNPs demonstrating statistical significance in the full analysis of renin across MESA race/ethnic groups.
Replication of SNP Associations in ARIC and the FHS
BP Traits
We examined SNPs across the KCNK3 gene in >10 000 participants from ARIC (Table S12 ) and >3700 FHS (Table S12) participants for replication of association with BP traits for the most strongly associated SNPs identified in MESA (Tables 3  and 4 ). In meta-analysis that combined all replication samples from ARIC and FHS, each of the identified KCNK3 SNPs examined showed nominally significant association with the most strongly associated BP trait identified in MESA (Table  S13 ; all nominal P<0.05). Among black participants from ARIC, we did not observe statistically significant evidence of replication (nominal P>0.05) although the directions of effect were overall consistent in this group.
Aldosterone
Aldosterone levels in the MESA white and FHS cohorts differed significantly (P<0.0001) with lower values observed in FHS whites, whereas PRA was not different (P=0.07). We suggest that higher aldosterone values in MESA whites may be attributable to greater disease progression as in aggregate MESA whites were on more antihypertensive medications.
In the full set of FHS participants, we did not find statistical evidence of replication for the association of rs2586886 with aldosterone (Table S14 , nominal P=0.559). However, in sensitivity analysis stratified by the use of hypertension medication, we identified a suggestion of association in participants with (nominal P=0.094) and without (nominal P=0.095) medication use, with opposing directions of effect (β=0.09, with medication use; β=−0.04, without medication use) concordant with those in the same strata among the MESA participants (Table 4) . Similar to MESA, we observed significant evidence of heterogeneity in the effects of KCNK3 rs2586886 on aldosterone levels based on medication use in FHS (Cochran Q heterogeneity P=0.026).
Hyperaldosteronism in TASK-1 Knockout Mice
In a previous rodent study, the global deletion of TASK-1 channels produced a highly significant 15-mm Hg increase in SBP in female mice, with a tendency toward elevated SBP in male mice. 17 Canrenoate, a blocker of the mineralocorticoid receptor, normalized SBP between genotypes, suggesting that hypertension was aldosterone dependent. Nevertheless, in that study, hyperaldosteronism was not detected in men and that observed in women did not arise from adrenal zona glomerulosa cells, but rather from a sex-dependent zonation defect in which aldosterone is made in the zona fasciculata.
To determine whether TASK-1 deletion causes hyperaldosteronism in animals in which adrenal zonation is normal and Cyp11b2 (aldosterone synthase) expression remains restricted to zona glomerulosa cells, 17 we studied the aldosterone/renin responses of male TASK-1 knockout mice to changes in dietary sodium. Rather than assess plasma aldosterone concentration, which captures the adrenal response at a single point in time, we used an integrated measure of aldosterone status, 24-hour urinary aldosterone excretion (urinary aldosterone normalized to creatinine) that better reports modest changes in production. 6, 13 Using this measure, we found that TASK-1 knockout mice overproduce aldosterone on all sodium diets from 36% to 73% (Figure [A] ). Although enhanced, aldosterone production from TASK-1 knockout mice remained under the control of the renin-angiotensin system. Thus, increasing dietary sodium lowered aldosterone production, whereas decreasing dietary Genetic association results for square-root transformed aldosterone levels (in ng/dL) reported under an additive 1 df single nucleotide polymorphism dosage model for rs2586886 effect allele C (other allele T). Analysis of aldosterone conducted with adjustment for sex, age, study site, and race-/ethnic-specific principal components of ancestry.
by guest on December 14, 2017 http://hyper.ahajournals.org/ Downloaded from sodium raised aldosterone production in both wild-type and TASK-1 knockout mice. TASK-1 knockout mice maintained normal renin status (Figure [B] ) on all sodium diets compared with wild-type mice (P=1.0, NS) in agreement with previous findings, 17 indicating that TASK-1 knockout mice are not a model of low renin-associated primary hyperaldostoneronism. 7 
Discussion
A substantial body of clinical and experimental data implicates aldosterone in the pathogenesis of hypertension, the prime example of which is primary aldosteronism, the most common secondary hypertensive disorder. 18, 19 Moreover, additional evidence in support of a relationship between circulating aldosterone and hypertension incident is the reported 1.6-fold increase in hypertension risk among individuals with serum aldosterone concentrations in the highest quartile relative to those in the lowest quartile. 20 Based on these studies and our own work characterizing the role of TASK channels in aldosterone-related hypertension, we hypothesized that previously reported genetic associations of KCNK3 with BP traits 21 may relate to the dysregulation of renin and aldosterone. We therefore conducted a GWAS of KCNK3 SNPs in relation to BP traits, hypertension, aldosterone, and PRA in MESA.
In analysis of BP traits, we replicated association of the previously reported 3, 4 KCNK3 SNP rs1275988 with MAP in MESA blacks. We did not examine the association of rs1275988 in MESA Hispanics because it failed the test for Hardy-Weinberg equilibrium. Nevertheless, we identified a nearby SNP with high LD (rs13394970) that demonstrated association with MAP in this group. We further identified another KCNK3 SNP, rs1731243, associated with SBP and hypertension status. Each of these SNP-trait associations replicated in the combined analysis of independent samples from ARIC and FHS, studies that have similar design and representative populations. The replication analysis did not achieve statistical significance in ARIC blacks alone although we observed overall consistent directions of effect in this group. In addition, we identified an aldosterone-associated SNP rs2586886 for which the C allele also demonstrated nominally significant evidence of association with increased SBP in MESA, an effect that replicated in the combined analysis of SBP in ARIC and FHS.
In examining replication of our selected SNPs from MESA in external cohorts, we recognize that European-ancestry samples from ARIC, MESA, and FHS were included in previous largescale GWAS efforts that identified the KCNK3 SNP rs1275988 in relation to SBP and MAP. 3 As a consequence, we note that our replication sample is not entirely independent of previously published work. However, the effect size of the identified SNPs on BP traits in MESA is notably larger than those observed in the replication cohorts. This observation may reflect, in part, the Winner curse 22 whereby effect estimates for SNPs are biased by the reporting of only those SNPs that reach a strict threshold for multiple comparisons. In addition, the larger effect sizes evident in MESA may reflect a better representation of the contemporary US population in which environmental and dietary factors that promote hypertension are ample and could magnify the contribution of genetic variation to BP and related traits.
Sensitivity analyses of the identified BP trait associated SNPs indicate the observed associations are strongest in women, subpopulations over the age of 60 years, and postmenopausal women. As BP itself rises with age, and in females postmenopause, it is noteworthy that the contribution of genetic variation in the KCNK3 gene to BP also becomes manifest at a later stage of life, as compensatory regulatory mechanisms decline. Thus, it is not surprising that our previous investigation that included teenagers and young adults did not identify KCNK3 SNPs demonstrating statistically significant associations with BP traits or aldosterone levels. 23 Furthermore, we note that this previous investigation used targeted genotyping of selected KCNK3 SNPs, and the SNPs reported in the current investigation were not included in that genotyping effort.
Interestingly, the rs2586886 SNP that associated with aldosterone levels in MESA showed significant evidence of heterogeneity with respect to antihypertensive medication status, with stronger effects of the C allele on increased aldosterone levels among participants on medication. Significance of this heterogeneity with respect to antihypertensive medication was also observed through replication in FHS. Although it is technically possible that this heterogeneity is caused directly by antihypertensive medication, we favor an alternate interpretation that medication suppressing the renin-angiotensin system unmasks the relationship between the C allele of rs2586886 and aldosterone to reveal dysfunction in the renin-angiotensin-aldosterone system. PRA was significantly suppressed in the MESA white, Hispanic, and Chinese participants taking β-blockers alone compared with the nonhypertensive group. As expected, blacks had low PRA whether they were taking β-blockers 24, 25 In the white, Hispanic, and Chinese participants on β-blockers alone, frank suppression of renin was not accompanied by the suppression of aldosterone secretion; plasma aldosterone levels in group I were similar to those in the nonmedicated, nonhypertensive group IV. Effect of diet on urinary aldosterone (UAldo) and plasma renin concentration (PRC). A, Twenty-four-hour UAldo/creatinine (ng/mg) of wild-type (WT; white bars) and T1KO mice (black bars) on each of 3 salt diets: low Na (0.02% Na-LS; n=25/13), normal Na (0.3% (Na-NS; n=38/14), high Na (2.0% Na-HS; n=32/13). B, PRC (mg of angiotensin [Ang] 1 per mL/h) of WT and T1KO mice on salt diets: low salt (LS; n=21/12), normal salt (NS; n=22/13), and high salt (HS; n=18/11). Values represent mean±SEM; *vs WT mice (P<0.05, 2-way ANOVA). Similarly, the response of group III participants to their antihypertensive medication is supported by high levels of PRA, yet these participants, with presumptively low levels of AT 1 receptor activation (a consequence of reduced Ang II generation [angiotensin-converting enzyme inhibitors] or AT 1 receptor inhibition [angiotensin receptor blockers]), maintained levels of aldosterone production that also were similar to those of group IV. Thus, the suppression of renin-angiotensin system by 2 classes of medication with divergent mechanisms of action provides substantial evidence for the association of the C allele with dysregulation of aldosterone production manifest as nonsuppressibility of secretion.
Although all of the KCNK3 SNPs analyzed were in strong LD with rs1275988 in EUR and ASN populations, LD was marginally reduced in AMR samples and considerably reduced in AFR samples. Based on the patterns of LD across race/ethnic groups, we suggest that the aldosterone-associated KCNK3 rs2586886 represents a site that is distinct from the previously reported MAP-associated SNP rs1275988. 21 The results in MESA and patterns of LD in the 1000 Genomes Project suggest that the previously reported MAP-associated SNP rs1275988 overlaps, in large part, the SNP most strongly associated with MAP (rs13394970) in the current investigation.
We have demonstrated that the global deletion of TASK-1 channels in mice produces a mild-hyperaldosteronism that is not associated with an increase in renin, suggesting either modest autonomous overproduction or an increased sensitivity to angiotensin II. Our studies build on the findings of Barhanin, Warth and colleagues who demonstrated that in TASK-1 knockout male mice aldosterone synthase localizes normally in the ZG layer. 17 However, in their animal cohort aldosterone production remained under strict control of the reninangiotensin system, an outcome that could be explained by the reported age-dependent increase in TASK-3 channel mRNA in their cohort that would compensate for TASK-1 channel deletion. 17 Also, these findings differ significantly from previous studies from our laboratory in which the deletion of TASK-3 channels alone (TASK-3 −/− ) 13 −/− mice in their aldosterone response to dietary sodium loading. The latter genotypes fail to suppress aldosterone output on a high salt diet. By contrast, TASK-1 knockout mice reduce aldosterone output when salt intake increases and renin activity is decreased, similar to wild-type mice. Thus, TASK-1 deletion alone does not recapitulate the low renin phenotype that is a characteristic of idiopathic primary hyperaldosteronism or low-renin essential hypertension, disorders that are associated with aldosterone production that is considered autonomous of the renin-angiotensin system. 7 Our findings in mice are consistent with the failure of the aldosterone-associated SNP (rs2586886) to associate with renin. As rs2586886 is in the first intron containing putative regulatory elements, we hypothesize that attenuation of human KCNK3 gene transcription may recapitulate the mild dysfunction of aldosterone production from zona glomerulosa cells in mice with TASK-1 channel deletion that we report here. In rodents, Kcnk3 and Kcnk9 genes are highly expressed in the zona glomerulosa layer 26 ; in contrast to the human adrenal cortex in which the expression of KCNK3 gene expression is dominant relative to other KCNK family members. 5 Thus, although a reduction in the expression of any active hyperpolarizing membrane conductance from the plasma membrane of zona glomerulosa cells would be expected to increase intracellular calcium, the critical second messenger that drives aldosterone production, 26 the extent of this increase, and thus the aldosterone size effect will depend on the relative activity of other active conductances in the membrane. Disease-causing variants in the exon-coding regions of several ion channels (KCNJ5, CACNA1D, and CACNA1H) expressed in the zona glomerulosa of the adrenal cortex have been discovered in patients with tumorigenic primary hyperaldosteronism that produce excessive levels of aldosterone or display marked and early-onset hypertension.
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Perspectives
We confirmed association of the previously reported KCNK3 rs1275988 with MAP in MESA blacks and identified additional association of KCNK3 SNPs with SBP, MAP, and hypertension status in MESA that replicated in independent samples from FHS and ARIC. We further identified a novel association of KCNK3 rs2586886 with increased aldosterone levels in MESA, the association of which demonstrated evidence of heterogeneity with respect to hypertension medication status in both MESA and FHS. Interpreted in the context of our mouse studies, our results suggest that genetic variation in the KCNK3 gene may contribute to less severe polygenic hypertensive disorders in which aldosterone dysregulation may be one of several contributing factors.
What Is New?
• Our study validates the KCNK3 gene as a new genetic locus for hypertension.
• Identified multiple new KCNK3 variants, within the same genomic region as a single previously reported allele, that associate with measures of blood pressure across race/ethnic groups.
• Discovered a distinct KCNK3 variant associating with nonsuppressible aldosterone and nominally with multiple blood pressure traits.
• Rodent studies demonstrate that genetic disruption of Kcnk3 produces hyperaldosteronism in a hypertensive model without a reduction in renin.
What Is Relevant?
• The most common forms of hypertension result from the cumulative burden of genetic variation at multiple loci. Our study identifies KCNK3 gene variants as potential drivers of hypertension and aldosterone across multiple race/ethic groups. One ancillary study (MESA Family Study, MESAFS) recruited 1,595 African American and Hispanic family members specifically for genetic studies, using the same inclusion and exclusion criteria as MESA except that clinical cardiovascular disease was permitted.
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ONLINE SUPPLEMENT
KCNK3 VARIANTS ARE ASSOCIATED WITH HYPERALDOSTERONISM AND HYPERTENSION
Another ancillary study (The MESA Air Pollution Study, MESA Air) evaluated the effects of air pollution on atherosclerosis risk, recruiting an additional 257 participants from Los Angeles and Riverside County, CA, and Rockland County, NY, using the same criteria as MESA, except that participants were ages 50 to 89 who lived in the area  50% of the year and had no plans to move in the next five years. 
Phenotyping of MESA participants
All MESA participants completed self-administered questionnaires at each visit and were interviewed by research staff about information pertaining to demographics, medical history, medication, and alcohol and tobacco use. Trained and certified clinic staff collected blood pressure (BP) and anthropometric measurements on all MESA participants at baseline. After a 5-minute rest, BP was measured on seated subjects 3 times at 1-minute intervals using the Dinamap PRO 100 automated oscillometric device (Critikon, Tampa, FL) with the back and arm supported. The average of the second and third BP readings was used for analysis. With the participant wearing light clothing, body mass index was calculated as weight in kilograms divided by height in meters squared.
Use of antihypertensive medication was based on self-report of use of medication from 1 of 6 common classes of antihypertensive medications (thiazide diuretics, angiotensin-converting enzyme inhibitors, angiotensin 2 receptor blocker, calcium channel blocker, β-blockers, and others (α-blockers, other peripheral vasodilators)).
Urine sodium and creatinine concentrations were measured at baseline for participants with spot urine samples available.
Genotype Data
Participants in the original MESA cohort, the MESA Family Study and the MESA Air Pollution Study who consented to genetic analyses were genotyped in 2009 using the Affymetrix Human SNP array 6.0. Genotype quality control for these data included filter on SNP level call rate < 95%, individual level call rate < 95%, heterozygosity > 53%, described previously. 3 The cleaned genotypic data was deposited with MESA phenotypic data into dbGaP as the MESA SHARe project (study accession phs000209); 8,224 consenting individuals (2,685 White, 2,588 3 non-Hispanic African-American, 2,174 Hispanic, 777 Chinese) were included, with 897,981 SNPs passing study specific quality control (QC). IMPUTE version 2.2.2 was used to perform imputation for the MESA SHARe participants using the cosmopolitan 1,000 Genomes Phase 1 v3 March 2012 reference set. 4 After applying race/ethnic-specific filters on minor allele frequency (MAF) > 0.01, Hardy-Weinberg Equibrium P-value > 10 -5 for genotyped SNPs and observed versus expected variance (oevar) > 0.5 for imputed SNPs 5 , there were 85, 192, 113, and 66 KCNK3 region SNPs available for genetic association analysis in MESA White, African American, Hispanic, and Chinese, respectively.
Principal component analysis
We performed principal component analysis to adjust for population structure among MESA participants, as described previously 3 . We constructed subsets of typed SNPs, thinned for linkage disequilibrium (LD) within each race/ethnic group. We performed Principal Component Analysis (PCA) as implemented in the program SMARTPCA 6, 7 for unrelated subsets of individuals, removing inferred first degree relatives from the analysis. We constructed histograms and QQ-plots to assess symmetry and normality of the distribution of loadings for each of the resulting PCs to determine the optimal number of PCs for genetic association analysis.
Selection of SNPs for genetic association analysis
We used dbSNP to identify the genomic region corresponding to KCNK3 as Chr 2 from 26,913,655 bp -26,954-537 bp, respectively, for human genome 19 (hg19) GRCh37.p5. Within this region, 8 SNPs were genotyped on Affy 6.0 and passed genotype QC. Through imputation to the 1,000 Genomes, we had information on another 517 KCNK3 SNPs in MESA. Allele frequencies were calculated separately within each race/ethnic group, and only those SNPs with MAF > 0.01 were included in genetic association analysis. We further filtered imputed SNPs based on imputation quality > 0.5, using the observed versus expected variance quality metric 5 , and filtered genotyped SNPs for Hardy-Weinberg Equilibrium (HWE) P-value ≥ 10 -5 . After applying these filters, we had 85, 192, 113, and 66 KCNK3 SNPs remaining for genetic association analysis in MESA White, African American, Hispanic, and Chinese, respectively.
Genetic association analysis in MESA
Traits of interest for genetic analyses included systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), pulse pressure (PP), prevalent hypertension (HTN), aldosterone and plasma renin activity (PRA). Analyses of BP traits were performed without variable transform, as their raw distributions were approximately normal. Analyses of aldosterone and PRA were performed under square-root and natural-log transforms, respectively, which yielded approximately normal phenotypic distributions.
To select individuals to be included in analysis, we began with the full MESA cohort. We stratified by race/ethnic group, and eliminated those individuals with top principal components of ancestry > 3.5 SD from the mean within any race/ethnic group. To allow study site to be included as a covariate in genetic association analysis within each race/ethnic group, we restricted the data set to individuals from study sites with data available for at least 20 individuals of that race/ethnic group. Genetic association analyses of each phenotype were then restricted to those participants with data available on that phenotype.
We began with stratified analyses within each race/ethnic group. For analysis of Caucasian and Chinese, and where there were insufficient families with phenotypes among African American and Hispanics, we first constructed an unrelated subset of individuals by selecting at most one individual from each pedigree, and performed linear regression of quantitative phenotypes or logistic regression of dichotomous phenotypes in R. 8 For analysis of blood pressure phenotypes with a substantial familial component among African American and Hispanic cohorts, we performed analysis using a linear mixed-effects model for quantitative traits, or generalized estimating equations for dichotomous traits, to account for familial relationships as implemented in the package R/GWAF. 9 Genetic association analyses of aldosterone and PRA were carried out under an additive 1 d.f. model with covariate adjustment for age, sex, study site and PCs of ancestry. Analyses of BP traits and hypertension included additional adjustment for age-squared and body mass index (BMI). Analysis of baseline blood pressure traits and hypertension status used age and BMI measurements assessed at Exam 1, while analysis of aldosterone and PRA incorporated examspecific age (either Exam 2 or Exam 3) corresponding to the time at which these traits were measured for each individual. Based on our examination of principal components within each race/ethnic group, as described above, we used 3 PCs for analysis of Caucasians, 1 PC for Chinese, 1 PC for African Americans, and 3 PCs for Hispanics. To account for multiple comparisons in each of the race/ethnic-specific analyses, we use an eigen-decomposition to estimate the effective number of independent SNPs in each race/ethnic group. 10, 11 The inferred numbers of independent SNPs were 33, 91, 49 and 12 for KCNK3 in Whites, African Americans, Hispanics and Chinese, respectively. Accordingly, all genetic analyses were assessed using a Bonferroni threshold for statistical significance that corrects for the effective number of independent SNPs identified within each race/ethnic group.
Following stratified analyses, we performed fixed effect meta-analysis to combine estimated effects and standard errors from race/ethnic stratified analyses, as implemented in METAL. 12 Primary SNP association results for the full cohort combined by meta-analysis were interpreted under Bonferroni correction for the effective number of independent SNPs, identified across race/ethnic groups for each gene, resulting in a threshold of *=0.05/91=5.5x10 -4 for KCNK3. We did not apply additional multiple comparisons correction for the number of traits under consideration. In addition to the primary genetic analyses described, we further performed sensitivity analyses using different covariate models and sub-strata, and results for these analyses are reported nominally without correction for multiple comparisons.
Replication cohorts
We sought replication of associated SNPs identified in MESA through examination of genetic association in participants from two independent replication cohorts, the Atherosclerosis Risk in Communities Study (ARIC) and the Framingham Heart Study (FHS) for whom GWAS genotyping were available to allow imputation of the identified SNPs of interest.
The Atherosclerosis Risk in Communities Study (ARIC):
The ARIC study is a multi-center prospective investigation of atherosclerotic disease in a predominantly bi-racial population (13) . White and African American men and women aged 45-64 years at baseline were recruited from 4 communities: Forsyth County, North Carolina; Jackson, Mississippi; suburban areas of Minneapolis, Minnesota; and Washington County, Maryland. A total of 15,792 individuals participated in the baseline examination in 1987-1989, with follow-up examinations in approximate 3-year intervals, during 1990-1992, 1993-1995, and 1996-1998 . For the purpose of the current analysis, we excluded participants with baseline CHD to create a subset of individuals comparable to MESA.
Phenotype and genotype data were obtained from dbGaP for the GENEVA ARIC Project (study accession phs000090). From a total of 841,820 genotyped SNPs (Affy 6.0 array) on 13,113 participants, we applied quality control filters for SNP level call rate > 0.95, sample level call rate > 0.95, sample heterozygosity > 0.33, and sex mismatch. To complete imputation of KCNK3 region SNPs, we identified 371 genotyped SNPs, in the region of this gene (including flanking regions of about 1 Mb on either side, NCBI build 37 Chr 2 Pos 25.9 -28.0 Mb), and used IMPUTE v2.3.0 (14) to complete imputation of additional SNPs in region from the 1,000 Genomes cosmopolitan Phase 1 v3 reference panel (15) . Using the observed versus expected variance metric (8) to quantify imputation quality, we set a threshold at imputation quality > 0.5 for inclusion in the current investigation. The SNPs identified for replication analyses were all either genotyped (rs1275988) or imputed with good quality in the ARIC Whites and African Americans (all imputation quality scores > 0.75).
The Framingham Heart Study (FHS):
The FHS was initiated in 1948 and comprised 5,209 men and women from the Framingham area who were between the ages of 28 and 62 years (16) . Beginning in 1971, FHS enrolled 5,124 additional men and women, who were either offspring of the original cohort or spouses of those offspring. In 2002, a total of 4,095 third generation participants (men and women) were recruited. During each clinic exam cycle, the participants underwent a detailed examination including physical examination, medical history, laboratory testing, and electrocardiogram. Over the years, other tests (not necessarily performed at every exam cycle) have included pulmonary function, lifestyle, physical function, cognitive function questionnaires, and various noninvasive cardiovascular tests including echocardiograms.
For the current effort, we created a subset of participants comparable to MESA in terms of age and health status, we limited our investigation to 2,565 Framingham Offspring (Exam 6) and 1,258 Generation 3 (Exam 1) participants age 45 or greater and free of CHD events.
Phenotype and genotype data were obtained from dbGaP for the Framingham SHARe Project (study accession phs000342). From a total of 500,568 genotyped SNPs (Affymetrix 500K) on 9,232 participants, we applied quality control filters for SNP level call rate > 0.95, sample level call rate > 0.95, sample heterozygosity > 0.32, and sex mismatch. To complete imputation of KCNK3 region SNPs, we identified 205 genotyped SNPs, respectively, in the regions of these two genes (including flanking regions of about 1 Mb on either side, NCBI build 37 Chr 2 Pos 25.9 -28.0), and used IMPUTE v2.3.0 (14) to complete imputation of additional SNPs in region from the 1,000 Genomes cosmopolitan Phase 1 v3 reference panel (15) . Using the observed versus expected variance metric (8) to quantify imputation quality, we set a threshold at imputation quality > 0.5 for inclusion in the current investigation. The SNPs identified for replication analyses were all either genotyped (rs1275988) or imputed with good quality in FHS (all imputation quality scores > 0.8).
Genetic association analysis in replication cohorts
Genetic analyses were performed using linear regression for quantitative traits and logistic regression for dichotomous traits under an additive model of inheritance. Regression models were constructed to follow as closely as possible with the regression models used for main genetic analysis performed in MESA (described in "Genetic association analysis in 6 MESA" above). Because the measures of blood pressure and aldosterone in FHS were conducted in both Offspring and Generation 3 participants, we further included adjustment for cohort in these analyses in FHS.
Measurement of aldosterone in TASK-1 KO mice TASK-1 KO mice were generated and backcrossed to a C57Bl/6J background as described previously. 13, 14 Male WT and T1KO mice between 60 and 100 days old were placed in metabolic cages and allowed to habituate for 4 days before the start of each dietary condition. Mice were given free access to normal Na + (NS, 0.3% Na + ), low Na + (LS, 0.02% Na + ) and high Na + (HS, 2.0% Na + ) diets for one week. All diets were developed by Teklad Laboratories (Madison, WI). Twenty-four hour urine samples were collected on the last 4 days of each diet and analyzed for aldosterone (radioimmunoassay [RIA], Siemens) and creatinine (colorimetric assay, Cayman Chemicals) concentrations. At the end of each dietary condition, tail vein samples were collected and plasma renin concentration was measured (RIA, Diasorin). Mice were allowed at least 1 week to recover in their home cages before receiving the next diet. Aldosterone/creatinine ratio and plasma renin concentration (PRC) were log transformed due to unequal variance among dietary conditions, and tested for significance using 2-way ANOVA and Bonferoni post hoc analysis. All animal studies were approved by the University of Virginia IRB and conducted according to the standards of the National Institutes of Health Guide for Care and Use of Laboratory Animals.
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SUPPLEMENTARY RESULTS
KCNK3 SNPs across race/ethnic groups in MESA and association with BP traits
Compared with the strongest MAP-associated SNP (rs1334970 , Table 3 ), rs1275988 had slightly stronger evidence of association with MAP in race/ethnic specific analyses in MESA (White, African American and Chinese, Table S2 ). Our identification of rs1334970 as the most associated SNP with MAP may reflect the fact that results for MESA Hispanics were filtered for rs1275988, resulting in an overall lower sample size in the meta-analysis for this SNP.
Comparison of the strength of association for these two SNPs by trans-ethnic meta-analysis MANTRA 16 restricted only to race/ethnic groups (White, African American, Chinese) with complete SNP information available further suggests stronger evidence of association for rs1275988 (log10 Bayes' Factor=1.74) than rs1334970 (log10 Bayes' Factor=1.54). Thus, our analysis supports the previously reported SNP rs1275988 and additional SNPs in this region within the KCNK3 gene as highly significant in association with BP phenotypes. Medication types included in our definition of hypertension medication include: thiazide diuretics, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, β-blockers, and others (α-adrenergic blockers, peripheral vasodilators). . †The discovery trait for rs2586886 was aldosterone (shown in Table 2 ). We present results for association with MAP here, since this trait showed the strongest association with rs2586886 among all the BP-related traits examined in MESA. Genetic association results for medication-corrected blood pressure traits reported under an additive 1 d.f. SNP dosage model with adjustment for sex, age, age 2 , body mass index, urinary sodium creatinine ratio, study site and race/ethnic specific PCs of ancestry. *Genetic association results not shown for MESA Hispanics since the SNP demonstrated strong deviation from Hardy-Weinberg Equilibrium (HWE) in this group (HWE p-value < 10 -7 ). †The discovery trait for rs2586886 was aldosterone (shown in Table 2 ). We present results for association with MAP here, since this trait showed the strongest association with rs2586886 among all the BP-related traits examined in MESA. Genetic association results for long-term average BP traits computed according to the approach used in . 17 For each of the five MESA Exams, residuals for each of the BP traits are computed after covariate adjustment for sex, age, age 2 , body mass index, study site and race/ethnic specific PCs of ancestry. *Genetic association results not shown for MESA Hispanics since the SNP demonstrated strong deviation from Hardy-Weinberg Equilibrium (HWE) in this group (HWE p-value < 10 -7 ). †The discovery trait for rs2586886 was aldosterone (shown in Table 2 ). We present results for association with MAP here, since this trait showed the strongest association with rs2586886 among all the BP-related traits examined in MESA. Genetic association results reported for effect allele C (other allele T) under an additive 1 d.f. model. Analysis of medication-corrected blood pressure traits and prevalent hypertension conducted with adjustment for sex, age, age 2 , body mass index, study site, and race/ethnic specific PCs of ancestry. Table 2 ). We present results for replication with MAP here, since this trait showed the strongest association with rs2586886 among all the BP-related traits examined in MESA. Genetic association results for square-root transformed aldosterone levels (in ng/dL) reported under an additive 1 d.f. SNP dosage model for rs2586886 effect allele C (other T). Analysis of aldosterone conducted with adjustment for sex, age, study site and race/ethnic specific PCs of ancestry.
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